Analytics Capabilities Updates
-
Pace Life Sciences Capabilities Update March 2026: Analytical Services
3/24/2026
A CDMO leader highlights two decades of growth, showcasing analytical strength, manufacturing, regulatory support, and integrated services that speed drug development.
-
Solvias Capabilities Update March 2026: Analytical Services
3/24/2026
A biotech leader highlights end‑to‑end analytical capabilities from development to commercialization, with expertise in biologics, gene therapies, quality testing, and regulatory solutions.
-
Catalent Capabilities Update March 2026: Analytical Services
3/24/2026
A biologics analytics leader showcases development, testing, and characterization capabilities, emphasizing quality, regulatory compliance, and integrated support from discovery to commercialization.
-
Recipharm Advanced Bio Capabilities Update March 2026: Analytical Services
3/24/2026
A lifecycle‑based analytical framework supporting release testing, stability studies, and product characterization to boost regulatory readiness, cut variability, and speed development.
-
Minaris Advanced Testing Capabilities Update March 2026: Analytical Services
3/24/2026
Access integrated biosafety testing, viral clearance, product characterization, and GMP analytics that deliver regulatory‑ready data and speed biologic and cell and gene therapy development.
-
Biosimilar Development: Early-Stage Characterization To QC Release
10/15/2025
SGS provides a complete range of bioanalytical solutions, including method development, validation and transfer; PK and PD Bioanalysis, ELISA and multiplex assays, bioassays, immunogenicity testing.
-
Mabion Capacity Update October 2025: Analytical Services
10/15/2025
We offer an end-to-end solution, covering every stage of biologic drug development, from early clone selection and small-scale manufacturing to process scale-up, large-scale production, and quality control.
-
Labcorp Biopharmaceutical CMC Services Capacity Update October 2025: Analytical Services
10/15/2025
Discover a streamlined formulation development workflow for mAbs to provide a more efficient process, driving down costs and reducing timelines, without compromising on quality and hence patient safety.
-
KBI Biopharma Capacity Update October 2025: Analytical Services
10/15/2025
Leveraging decades of expertise, analytical capabilities, and regulatory knowledge, we deliver phase-appropriate solutions that streamline development, reduce risk, and accelerate timelines from discovery through commercialization.
-
Alcami Capacity Update October 2025: Analytical Services
10/15/2025
Whether you're preparing for IND, scaling commercial operations, or navigating complex regulatory pathways, gain actionable strategies and updates to help you move forward with confidence.